Stryker announces nomination of new Director, Lisa Skeete Tatum
February 25 2020 - 8:08AM
Stryker (NYSE:SYK) announced that Lisa Skeete Tatum has been
nominated for election to the company’s Board of Directors at
Stryker’s 2020 Annual Meeting of Shareholders, which will be held
on May 5, 2020.
Ms. Skeete Tatum is the Founder and Chief Executive Officer of
Landit, Inc., a technology platform created to increase the success
and engagement of women and diverse groups in the workplace. Her
previous experience includes over a decade as an early stage
venture capitalist focused on investments in healthcare technology.
Ms. Skeete Tatum also worked for Procter & Gamble and has
served on numerous private and public boards.
“We are excited about the potential to add Lisa to our board,”
said Kevin Lobo, Stryker’s Chairman and Chief Executive Officer.
“She brings a strong background in healthcare investing and
technology as well as deep insight on talent development that we
believe will benefit our board and company.”
Stryker is one of the world’s leading medical technology
companies and, together with its customers, is driven to make
healthcare better. The company offers innovative products and
services in Orthopaedics, Medical and Surgical, and Neurotechnology
and Spine that help improve patient and hospital outcomes. More
information is available at www.stryker.com.
Important Additional Information and Where You Can Find
It
The Company, its directors and certain of its executive officers
may be deemed to be participants in a solicitation of proxies from
the Company’s shareholders at the 2020 Annual Meeting of
Shareholders in connection with the director nomination disclosed
above. Information regarding the Company’s directors and
executive officers and their respective interests in the Company,
by security holdings or otherwise is set forth in the Company’s
Definitive Proxy Statement for its 2019 Annual Meeting of
Shareholders, filed with the Securities and Exchange Commission
(the “SEC”) on March 20, 2019 and reports filed by the Company and
ownership forms filed by the directors and executive officers with
the SEC. The Company urges its shareholders to carefully
read the Definitive Proxy Statement for its 2020 Annual Meeting of
Shareholders, and any other relevant documents filed by the Company
with the SEC, when available because they will contain important
information. Shareholders may obtain free copies of the
materials referenced above at www.sec.gov or www.stryker.com.
For investor inquiries please contact:
Katherine Owen, Vice President, Strategy & Investor Relations at 269-385-2600 or katherine.owen@stryker.com
For media inquiries please contact:
Yin Becker, Vice President, Communications, Public Affairs and Corporate Marketing at 269-385-2600 or yin.becker@stryker.com
Stryker (NYSE:SYK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Stryker (NYSE:SYK)
Historical Stock Chart
From Apr 2023 to Apr 2024